Global Bioenergies (ALGBE) | Financial Analysis & Statements
Global Bioenergies S.A. Small-cap Utilities
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
9.7M
Total Liabilities
8.0M
Shareholders Equity
1.7M
Debt to Equity
4.70
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2024
Global Bioenergies Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 360.7K | 3.2M | 697.5K | 100.9K | 63.8K |
| Cost of Goods Sold | 574.4K | 3.3M | -1.1M | 680.7K | -282.6K |
| Gross Profit | -213.7K | -83.6K | 1.8M | -579.8K | 346.5K |
| Gross Margin % | -59.3% | -2.6% | 260.3% | -574.4% | 542.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 196.0K | 281.1K | 413.8K | 1.4M | 151.4K |
| Other Operating Expenses | 3.2M | 5.4M | 8.7M | 8.1M | 8.5M |
| Total Operating Expenses | 3.4M | 5.7M | 9.1M | 9.6M | 8.6M |
| Operating Income | -6.1M | -6.8M | -11.6M | -12.2M | -13.0M |
| Operating Margin % | -1,689.5% | -207.7% | -1,662.9% | -12,051.3% | -20,404.9% |
| Non-Operating Items | |||||
| Interest Income | 1.7K | 81 | 27 | 20 | 21 |
| Interest Expense | 299.0K | 123.3K | 124.4K | 114.5K | 198.5K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -7.1M | -9.8M | -13.4M | -13.5M | -13.2M |
| Income Tax | -1.3M | -1.2M | -1.4M | -1.7M | -2.3M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -5.9M | -8.7M | -12.0M | -11.8M | -10.9M |
| Net Margin % | -1,625.1% | -266.4% | -1,718.4% | -11,664.0% | -17,087.5% |
| Key Metrics | |||||
| EBITDA | -3.5M | -5.3M | -11.1M | -11.3M | -9.6M |
| EPS (Basic) | - | €-0.48 | €-0.80 | €-0.78 | €-1.08 |
| EPS (Diluted) | - | €-0.48 | €-0.80 | €-0.78 | €-1.08 |
| Basic Shares Outstanding | - | 18149196 | 14988606 | 15099491 | 10291665 |
| Diluted Shares Outstanding | - | 18149196 | 14988606 | 15099491 | 10291665 |
Income Statement Trend
Global Bioenergies Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 4.7M | 11.7M | 8.8M | 20.9M | 14.5M |
| Short-term Investments | 170.5K | 170.5K | 173.1K | 146.6K | 360.2K |
| Accounts Receivable | 13.1K | 19.5K | 79.5K | 16.7K | 19.6K |
| Inventory | 401.9K | 568.8K | 2.6M | 2.0M | 2.0M |
| Other Current Assets | - | - | - | - | 1.5K |
| Total Current Assets | 8.7M | 15.0M | 15.5M | 26.9M | 21.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 13.7M | - | 13.4M | 10.5M | 17.5M |
| Goodwill | 69.2K | 565.8K | 1.0M | 1.5M | 1.9M |
| Intangible Assets | 69.2K | 88.8K | 61.6K | 84.6K | 25.7K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1 | - | -1 | -1 | -1 |
| Total Non-Current Assets | 904.4K | 3.2M | 6.1M | 4.9M | 3.9M |
| Total Assets | 9.7M | 18.3M | 21.6M | 31.8M | 25.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.5M | 2.4M | 5.6M | 3.5M | 2.7M |
| Short-term Debt | 3.9M | 1.5M | 1.4M | 2.2M | 7.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | 1.5M | 1.4M | 3.0M |
| Total Current Liabilities | 6.0M | 3.0M | 7.4M | 7.9M | 16.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.8M | 4.8M | 6.4M | 5.1M | 151.1K |
| Deferred Tax Liabilities | 0 | 1 | 0 | 0 | - |
| Other Non-Current Liabilities | - | 2 | -1 | -2 | 1.8M |
| Total Non-Current Liabilities | 2.0M | 4.9M | 6.5M | 5.2M | 334.3K |
| Total Liabilities | 8.0M | 7.8M | 13.9M | 13.1M | 16.6M |
| Equity | |||||
| Common Stock | 908.4K | 906.4K | 749.4K | 743.3K | 506.6K |
| Retained Earnings | -5.9M | -8.7M | -12.0M | -16.5M | -92.4M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.7M | 10.4M | 7.6M | 18.7M | 9.2M |
| Key Metrics | |||||
| Total Debt | 5.7M | 6.3M | 7.8M | 7.4M | 8.1M |
| Working Capital | 2.8M | 12.1M | 8.0M | 19.0M | 5.7M |
Balance Sheet Composition
Global Bioenergies Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -5.9M | -8.7M | -12.0M | -11.8M | -11.1M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | -8.9M | -8.7M | -12.0M | -11.8M | -11.1M |
| Investing Activities | |||||
| Capital Expenditures | -466.0K | -325.4K | -2.0M | 3.5K | - |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | 0 | 1.2M | 18.0K | 351.7K | - |
| Investing Cash Flow | -466.0K | 887.5K | -1.9M | 355.2K | - |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 1.0M | 25.1K | - | 1.1M | 4.9M |
| Debt Repayment | -213.4K | -1.6M | -970.5K | -1.3M | -1.2M |
| Financing Cash Flow | 990.1K | 3.4M | -125.4K | 21.2M | 9.6M |
| Free Cash Flow | -8.0M | -8.2M | -12.1M | -14.7M | -11.3M |
| Net Change in Cash | -8.3M | -4.4M | -14.1M | 9.8M | -1.5M |
Cash Flow Trend
Global Bioenergies Key Financial Ratios
No financial ratio data available.
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| Engie S.A | 71.9B | 18.73 | 2.41 | 11.54% | 5.32% | 135.16 |
| Methanor S.C.A | 6.2M | 4.45 | 0.44 | -5.54% | 8,916.14% | 0.00 |
| Weyerhaeuser Company | 1.2M | - | - | -3,272.22% | 2.43% | - |
| Electricité de | 1.6B | 10.36 | 2.68 | 28.10% | 11.66% | 1.73 |
| Voltalia S.A | 928.2M | 30.00 | 0.92 | -9.32% | -21.80% | 237.90 |
Financial data is updated regularly. All figures are in the company's reporting currency.